ECSP034517A - Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina - Google Patents

Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina

Info

Publication number
ECSP034517A
ECSP034517A EC2003004517A ECSP034517A ECSP034517A EC SP034517 A ECSP034517 A EC SP034517A EC 2003004517 A EC2003004517 A EC 2003004517A EC SP034517 A ECSP034517 A EC SP034517A EC SP034517 A ECSP034517 A EC SP034517A
Authority
EC
Ecuador
Prior art keywords
amino
treatment
imidazolidine
phenil
imino
Prior art date
Application number
EC2003004517A
Other languages
English (en)
Spanish (es)
Inventor
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Ikunobu Muramatsu
Kenji Sakai
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034517A publication Critical patent/ECSP034517A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EC2003004517A 2000-10-14 2003-03-17 Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina ECSP034517A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14

Publications (1)

Publication Number Publication Date
ECSP034517A true ECSP034517A (es) 2003-04-25

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004517A ECSP034517A (es) 2000-10-14 2003-03-17 Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina

Country Status (23)

Country Link
EP (1) EP1328517A2 (pl)
JP (1) JP2004511547A (pl)
KR (1) KR20030046503A (pl)
CN (1) CN1471514A (pl)
AR (1) AR035923A1 (pl)
AU (1) AU2002215943A1 (pl)
BG (1) BG107711A (pl)
BR (1) BR0114603A (pl)
CA (1) CA2425563A1 (pl)
CZ (1) CZ20031333A3 (pl)
DE (1) DE10150312A1 (pl)
EA (1) EA200300460A1 (pl)
EC (1) ECSP034517A (pl)
EE (1) EE200300177A (pl)
HU (1) HUP0302245A3 (pl)
IL (1) IL155338A0 (pl)
MX (1) MXPA03003162A (pl)
NO (1) NO20031697L (pl)
PL (1) PL361359A1 (pl)
SK (1) SK4342003A3 (pl)
WO (1) WO2002032876A2 (pl)
YU (1) YU28203A (pl)
ZA (1) ZA200302345B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
HUP0302245A3 (en) 2004-01-28
WO2002032876A3 (de) 2002-07-18
HUP0302245A2 (hu) 2003-10-28
BG107711A (en) 2004-02-27
BR0114603A (pt) 2003-10-14
NO20031697D0 (no) 2003-04-11
IL155338A0 (en) 2003-11-23
AU2002215943A1 (en) 2002-04-29
SK4342003A3 (en) 2003-10-07
PL361359A1 (pl) 2004-10-04
MXPA03003162A (es) 2004-12-06
JP2004511547A (ja) 2004-04-15
EE200300177A (et) 2003-08-15
EP1328517A2 (de) 2003-07-23
CA2425563A1 (en) 2002-04-25
YU28203A (sh) 2006-05-25
ZA200302345B (en) 2004-04-23
KR20030046503A (ko) 2003-06-12
WO2002032876A2 (de) 2002-04-25
CZ20031333A3 (cs) 2003-08-13
DE10150312A1 (de) 2002-07-04
AR035923A1 (es) 2004-07-28
EA200300460A1 (ru) 2004-02-26
CN1471514A (zh) 2004-01-28
NO20031697L (no) 2003-05-26

Similar Documents

Publication Publication Date Title
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
BRPI0408024A (pt) combinações antineoplásicas, compreendendo um derivado de rapamicina e um inibidor de aromatase
PT1351958E (pt) Imidazolo-5-il-2-anilino-pirimidinas como agentes para a inibicao da proliferacao celular
HN2000000267A (es) Oxazolidinonas substituidas y su uso
UY27604A1 (es) Compuestos químicos.
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
ATE302775T1 (de) Carbolinderivate
UY29213A1 (es) Derivados de quinolina e isoquinolina 5-sustitiuidos, un procedimiento para su preparación y su uso como inhibidores de la inflamación
ATE346067T1 (de) Carbolinderivate
UY28360A1 (es) Nuevos compuestos
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
SV2006002220A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios ref. p-sv-78.836/cd
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
ATE302776T1 (de) Kondensierte pyridoindolderivate
ATE259813T1 (de) Triazolopyrimidinderivate
ECSP034517A (es) Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
UY26961A1 (es) Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina
AR005704A1 (es) Heteroariloxazolidinonas
ES2166026T3 (es) Derivados de 1,2,3-benzotiadiazol y su uso como microbicidas.
ECSP034700A (es) Nuevos derivados de m-alquil-fenilimino-imidazolidana para tratar la incontinencia urinaria
UY27157A1 (es) Nuevos derivados de alquil-fenilimino-imidazolidina para el tratamiento de la incontinencia urinaria